← Evidence map

ArticleBiomedicines2022

CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma.

Jimena Álvarez Freile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35625912